Raiffeisen Bank International’s Edwards Lifesciences EW Stock Holding History

Raiffeisen Bank International’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$22.9M	Sell	288,455 -21,662	-7%	-$1.79M	0.33%	79
2025 Q4	$26.7M	Buy	310,117 +220	+0.1%	+$18.1K	0.34%	79
2025 Q3	$23.9M	Buy	309,897 +9,622	+3%	+$752K	0.32%	81
2025 Q2	$23.1M	Sell	300,275 -369	-0.1%	-$27.5K	0.34%	82
2025 Q1	$21.3M	Sell	300,644 -20,691	-6%	-$1.48M	0.34%	85
2024 Q4	$23.9M	Buy	+321,335	New	+$22.5M	0.36%	77

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Raiffeisen Bank International's EW Position: Q1 2026 in Review

Raiffeisen Bank International reduced its Edwards Lifesciences (EW) stake by 7% in Q1 2026, selling an estimated $1.79M and leaving 288,455 shares worth $22.9M. The position accounts for 0.33% of the portfolio, ranked #79.

Raiffeisen Bank International first reported a position in EW in Q4 2024 and has held it in 6 quarters since. The position peaked at $26.7M in Q4 2025. 1,284 funds tracked by Wall St. Rank hold EW as of Q1 2026.

Raiffeisen Bank International held 288,455 shares of Edwards Lifesciences worth $22.9M as of Q1 2026.
Raiffeisen Bank International sold 21,662 Edwards Lifesciences shares in Q1 2026, an estimated $1.79M.
Edwards Lifesciences made up 0.33% of Raiffeisen Bank International's portfolio in Q1 2026, its #79 holding.
Raiffeisen Bank International first reported a position in Edwards Lifesciences in Q4 2024 and has held it in 6 quarters since.
Raiffeisen Bank International's Edwards Lifesciences position peaked at $26.7M in Q4 2025.
1,284 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Raiffeisen Bank International's 13F filing for Q1 2026, filed 24 Apr 2026.